Sensitization of human colon cancer cells to TRAIL-mediated apoptosis

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
A HernandezB Mark Evers

Abstract

TNF-related apoptosis-inducing ligand (TRAIL), a novel member of the tumor necrosis factor (TNF) family, is thought to induce apoptosis preferentially in cancer cells; however, increasing evidence suggests that a number of cancers are resistant to TRAIL treatment. FLICE-like inhibitory protein (FLIP), which structurally resembles caspase-8, can act as an inhibitor of apoptosis when expressed at high levels in certain cancer cells. The purpose of our present study was to determine whether human colon cancer cells are sensitive to TRAIL treatment and, if not, to identify potential mechanisms of resistance. Colon cancer cells of different metastatic potential (KM12C, KML4A, and KM20) were found to be resistant to the effects of TRAIL when used as a single agent. FLIP expression levels were increased in all three KM cell lines. Treatment with either actinomycin D (Act D;10 :g/ml) or cycloheximide (CHX; 10 :g/ml) decreased FLIP expression levels in all three cell lines. The decrease in cellular levels of FLIP was associated with sensitization to TRAIL-mediated apoptosis, as demonstrated by enhanced cell death and caspase-3 activity compared with either Act D or CHX alone. Our findings suggest that reduction of FLIP levels by Act D o...Continue Reading

Citations

Sep 5, 2015·BioMed Research International·Ludmila LozneanuIrina-Draga Căruntu
Feb 29, 2008·Yonsei Medical Journal·Jin Kuk Yang
Apr 1, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Ya-Ping ZhangKwen-Jen Chang
Apr 18, 2015·Frontiers in Oncology·Rachana Trivedi, Durga Prasad Mishra
May 18, 2005·Oncogene·Thiyam Ramsing SinghRakesh K Srivastava
Aug 23, 2006·Future Oncology·Donald J BuchsbaumAlbert F Lobuglio
Jan 9, 2009·Apoptosis : an International Journal on Programmed Cell Death·Beata PajakArkadiusz Orzechowski
May 7, 2004·Biology of Reproduction·Joan K RileyKelle H Moley
Feb 16, 2005·Apoptosis : an International Journal on Programmed Cell Death·S BouralexisA Evdokiou
Mar 19, 2008·Apoptosis : an International Journal on Programmed Cell Death·Lenka DoubravskáLadislav Andera
Mar 19, 2008·Apoptosis : an International Journal on Programmed Cell Death·Beata PajakBarbara Gajkowska
Jun 12, 2003·World Journal of Gastroenterology : WJG·Li-Hong XuDong-Zhou Liu
Jul 17, 2003·British Journal of Cancer·C M M van GeelenS de Jong
Jul 6, 2012·Expert Opinion on Therapeutic Targets·Markus David Siegelin
Apr 1, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Samira GoldarBehzad Baradaran
Feb 5, 2003·Drug Discovery Today·Marek LosAndrzej Mackiewicz
Jun 29, 2004·Cancer Letters·Irina A DavidovichVictor V Levenson Chernokhvostov
Mar 26, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Caroline M M Van GeelenSteven de Jong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis